top of page
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
The use of chlordiazepoxide for outpatient gamma-butyrolactone (GBL) detoxification: An observational study
Various detoxification regimens are used for gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL), including diazepam, barbiturates, ba
Alfred Balston, Kuljit Hunjan and more
Apr 6, 20232 min read
Why do drugs have so much stigma?
Written by Nikol Naydenova – Imperial College London undergraduate & Drug Science Honorary Research Assistant Having grown up in a...
Nikol Naydenova
Apr 5, 20233 min read
Creating better teaching resources for secondary school drug education
Written by Hannah Dawes – Head of Personal, Social, Health and Economic (PSHE) education at King Edward’s School, Bath, UK Last year, The...
Hannah Dawes
Apr 4, 20232 min read
Taking matters into my own hands: Self-taught drug education
Written by AJ Martin – President of the Imperial College Students for Sensible Drug Policy Engaging in the drug science and policy space...
AJ Martin
Apr 3, 20233 min read
The Drug Science podcast returns with two new co-hosts!
The Drug Science Podcast returns on March 29th 2023. This season, Drug Science has been interviewing some of the brightest minds in...
Drug Science
Mar 29, 20234 min read
No Laughing Matter: The Nonsense Plan to Criminalise Nitrous Oxide
By Professor David Nutt Placing Nitrous Oxide in the Misuse of Drugs Act 1971 Yesterday Michael Gove announced the government’s plan to...
Professor David Nutt
Mar 28, 20239 min read
Preliminary findings from T21 Australia
An observational study of patients prescribed medicinal Cannabis for chronic pain, anxiety, posttraumatic stress disorder and multiple...
Kylie O’Brien, Justin Beilby and more
Mar 23, 20232 min read
Combating the stigma: a T21 success story
By Louise McConnell Although medical cannabis has been legal in the UK for more than four years, there still exists a great deal of...
Louise McConnell
Mar 20, 20232 min read
Medication sparing after medical cannabis initiation: A case study of a chronic pain patient in T21
Authors Peter Sunderland, David J Nutt, and Anne Katrin Schlag Published March 14th, 2023 Prescribed cannabinoids are legal in the UK and...
Peter Sunderland, Professor David Nutt and more
Mar 14, 20232 min read
Drug Science submits evidence to the ACMD Nitrous Oxide Review
The Advisory Council on the Misuse of Drugs (ACMD) is collecting written evidence regarding the health and social harms of nitrous oxide....
Drug Science
Mar 2, 20238 min read
Grow Pharma joins T21
Drug Science is pleased to welcome Grow Pharma as a partner on its groundbreaking medical cannabis study, T21. Launched in 2019, T21 is...
Drug Science
Feb 24, 20232 min read
Parents and scientists back new study into benefits of cannabis-based medications for children with severe epilepsy
Today, on International Epilepsy Day, patient group MedCan Support, scientific body Drug Science and tech-platform Alta Flora announce...
Drug Science
Feb 13, 20233 min read
Psychedelics for managing pain
Dr. Joanna Kempner Dr. Joanna Kempner is a professor of sociology at Rutgers University, where she studies the overlap of science,...
Drug Science
Feb 2, 20234 min read
Drug Science’s medical cannabis patient registry (T21) sees departure of Lyphe Group and introduces new pricing model
The subsidised pricing structure of Drug Science’s medical cannabis registry, ‘T21’, is changing to a new model. Until now, T21 has...
Drug Science
Jan 24, 20231 min read
Response from Drug Science to the Australian Government consultation on potential reforms to the regulation of nicotine vaping products
Border controls No legislative changes ought to be made to Australia’s current border controls for nicotine products. The black market...
Drug Science
Jan 19, 20239 min read
Drug Science’s medical cannabis patient registry (T21) to continue for a fourth year
Today (16 January 2023) Drug Science announces that its medicinal cannabis patient registry ‘T21’ is continuing for a fourth year — and...
Drug Science
Jan 16, 20234 min read
Neuroplasticity in Mental Health Recovery: Prompting the Brain to Cure Itself
Written by Tiago Vasconcelos Psychiatric disorders can be considered to disturb the brain’s equilibria, emerging when different factors...
Tiago Vasconcelos
Jan 5, 20238 min read
Catch up on the UK Patient Conference
Watch some of the day’s highlights The first UK Patient Conference took place during Medical Cannabis Awareness Week on Friday 4th...
Drug Science
Jan 4, 20235 min read
Busting the Myths Surrounding Psychedelics
Prof. Jo Neill The generalised public perception of psychedelic drugs is rooted in their legal categorisation as a Class A, Schedule 1...
Drug Science
Dec 28, 20224 min read
50 Years of Failed Drug Policy – Event Review
By Karolina Wilgus Since 1971, The Misuse of Drugs Act (MDA) has yielded suffering, halted life-saving research, and put overwhelming...
Karolina Wilgus
Dec 22, 20223 min read
Three weeks down under: My Mind Medicine Australia Psychedelic Lecture Tour
Written by Professor David Nutt I have just come back from a 3-week lecture tour of South-Eastern Australia supporting the cause of the...
Professor David Nutt
Dec 8, 20225 min read
Response to Bertha Madras editorial in the New England Journal of Medicine
Response by: Prof David Nutt – FMedSci Imperial College London Prof Jo Neill – PhD University of Manchester On behalf of Drug Science We...
Drug Science
Dec 1, 20224 min read
Would you let your teenager try psychedelics?
By Alice Lineham *Note that throughout this article the term ‘teenager’ is used to refer to individuals between the ages of 13-18 Since...
Alice Lineham
Nov 15, 202210 min read
The United Kingdom's Psychoactive Substances Act 2016. Where are we now?
Authors Christopher Humphries Published November 14th, 2022 This narrative review describes the background to the introduction of the UK...
Christopher Humphries
Nov 14, 20221 min read
bottom of page